Decreasing level of serum ADA: A valuable predictor of treatment in smear positive tuberculosis Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011
The diagnosis value of the ADA isoenzymes activity in tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 155s Year: 2003
Evaluation of sICAM-1 as a serum marker for follow-up of pulmonary tuberculosis therapy Source: Eur Respir J 2005; 26: Suppl. 49, 454s Year: 2005
The worth of serum adenosine deaminase levels in patients with pulmonary tuberculosis for follow-up the disease Source: Eur Respir J 2004; 24: Suppl. 48, 425s Year: 2004
The diagnostic value of induced-sputum in patients with tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 160s Year: 2003
Clinical significance of low serum isoniazid level among the patients with drug-sensitive pulmonary tuberculosis who showed delayed smear or culture conversion. Source: International Congress 2018 – New developments in tuberculosis Year: 2018
The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
High serum CA-125 level in active pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 415s Year: 2005
Comparison of serum CA-125 levels in pulmonary tuberculosis, pleural tuberculosis and treated active pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 453s Year: 2005
A comparative study on serum ADA levels in cavitary and non-cavitary pulmonary tuberculosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 160s Year: 2003
The significance of IP-10 level in blood serum for TB diagnosis in patients with late-stage HIV infection Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019
The value of interferon (IFN)-γ blood tests in diagnosis of tuberculosis Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007
Relationship between levels of serum adenosin deaminase (ADA) and sputum smear conversion in patients with pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 425s Year: 2004
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008
One year follow-up of T-SPOT. TB results in treated patients with active tuberculosis Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007
Serum adenosine deaminase (ADA) activities and neopterine levels during therapy in patients with pulmonary tuberculosis and community-acquired pneumonia Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis? Year: 2010
Usefulness of serum procalcitonin levels in pulmonary tuberculosis Source: Eur Respir J 2011; 37: 371 Year: 2011
The use of ADA liquid level in diagnosis of tuberculous pleurisy in countries with low incidence of tuberculosis Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions Year: 2011
Serological response after tuberculosis treatment: two-years follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 468s Year: 2001
Is neopterin concentration predictive in latent tuberculosis infection in health workers? Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008